Validation of a clinical guideline on prevention of venous thromboembolism in medical inpatients: a before-and-after study with systematic ultrasound examination

J Intern Med. 2004 Oct;256(4):338-48. doi: 10.1111/j.1365-2796.2004.01365.x.

Abstract

Background: Clinical practice guidelines on prevention of venous thromboembolism in medical inpatients have been implemented in various settings, although few studies have assessed their impact on venous thromboembolism events.

Objective: To determine whether the implementation of a locally developed guideline is followed by changes in the rate of deep vein thrombosis.

Design: A before-and-after study consisting in two "1-day" cross-sectional studies.

Setting: Thirteen adult medical wards in a teaching hospital in France.

Subjects: All the patients hospitalized on the day of the cross-sectional study.

Intervention: A clinical guideline integrating scientific evidence and data on target medical providers' practices was developed by a local expert panel and implemented through a multifaceted intervention.

Measurements: Prevalence of deep vein thrombosis detected by systematic ultrasound examination.

Results: The study included 338 patients in the preintervention sample and 340 in the postintervention sample. The prevalence of deep vein thrombosis decreased from 9.5% (95% CI, 6.6-13.1) in the preintervention sample to 3.2% (95% CI, 1.6-5.7) in the postintervention sample (P < 0.01). The decrease in the rate of thrombosis involved all deep veins of the lower limbs and remained significant after adjustment for risk factors (adjusted odds ratio = 0.47, 95% CI, 0.32-0.70). No additional cases of pulmonary embolism or deep vein thrombosis were reported either on the day of the study or in the following 2 days.

Conclusions: Active implementation of a clinical practice guideline directed at medical providers (doctors, nurses and physical therapists) can be followed by a significant decrease in prevalence of deep vein thrombosis.

Publication types

  • Validation Study

MeSH terms

  • Aged
  • Bandages
  • Cross-Sectional Studies
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heparin, Low-Molecular-Weight / therapeutic use
  • Humans
  • Male
  • Practice Guidelines as Topic*
  • Pulmonary Embolism / diagnostic imaging
  • Pulmonary Embolism / prevention & control
  • Risk Factors
  • Ultrasonography
  • Venous Thrombosis / diagnostic imaging
  • Venous Thrombosis / prevention & control*

Substances

  • Fibrinolytic Agents
  • Heparin, Low-Molecular-Weight